A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones
Wei Liu(Arizona State University), Yuping Mei(Johns Hopkins Hospital), Peng Huang(Johns Hopkins University), Zhihao Lü(Nanjing Tech University), Hamza Khan(Johns Hopkins University), James R. Eshleman(Johns Hopkins University), Xin Jin(Capital Medical University), Nadege Fackche(Johns Hopkins University), Wasay Nizam(Johns Hopkins University), Hongchan Huang(Chinese Academy of Sciences), Xiangqian Kong(University of Science and Technology of China), Yi Zhang, Yanfei Li(Henan University of Technology), Yuyan Wang(Yangtze University), Xin Zhao(Soochow University), Naixin Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Lai(Johns Hopkins University), Charles Conover Talbot(Johns Hopkins University), Malcolm V. Brock(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Haibo Liu(Fermi National Accelerator Laboratory), Beverly Lee(Lovelace Respiratory Research Institute)
Cited by 9
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Microsatellite Instability as a Biomarker for PD-1 Blockade
|Clinical Cancer Research|2016|982
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|909